Investments and personal finance

Home: Welcome

My view on what's going on in the financial markets and the global economy, and a few other things that might interest me from time to time.

tim@emorningcoffee.com

3 days ago7 min read

Portfolio update: 4Q2024 and full year

This article contains an update of my 2024 portfolio performance. My returns were decent but not as good as they should have been.

tim@emorningcoffee.com

Jan 31 min read

This article contains a summary of full-year 2024 performance of the indices and assets tracked by EMC, plus historical data, too.

tim@emorningcoffee.com

Dec 31, 20248 min read

I "guessed" at how markets would perform in 2024 last year at this time. Some I got right, some I got wrong, not different from the pros.

tim@emorningcoffee.com

Oct 9, 20249 min read

This is the update of my personal portfolio for the most recent quarter ended September 30, 2024.

tim@emorningcoffee.com

Jul 24, 20248 min read

This is an update of my personal portfolio performance in 2Q2024 and 1H2024, good on the surface but worse than the indices would suggest.

tim@emorningcoffee.com

May 2, 202414 min read

The 2024 en primeur campaign for Bordeaux is just starting. But is fine wine really a good investment? I don't think so anymore.

tim@emorningcoffee.com

Apr 10, 20248 min read

This is an update about my personal portfolio during and at the end of 1Q2024. It also discusses performance which I consider disappointing.

tim@emorningcoffee.com

Mar 18, 20248 min read

This is the 3rd and final article focused on anti-obesity drugs. It looks at valuations of shares of the two giants in this biz, LLY & NVO.

tim@emorningcoffee.com

Mar 14, 20247 min read

Eli Lilly (LLY) and Novo Nordisk (NVO) have been large players for decades in the market for diabetes medications and are currently...

Home: Blog2